Invesco Ltd. - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 90 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$192,466
-95.9%
31,043
-93.7%
0.00%
-100.0%
Q1 2024$4,688,650
+45.9%
496,679
+4.3%
0.00%0.0%
Q4 2023$3,214,391
+8945.4%
476,206
+3719.1%
0.00%
Q1 2023$35,536
-62.4%
12,469
-3.9%
0.00%
Q4 2022$94,479
+5.0%
12,978
+15.5%
0.00%
Q3 2022$90,000
+63.6%
11,241
+1.3%
0.00%
Q2 2022$55,000
-99.0%
11,100
-95.0%
0.00%
-100.0%
Q1 2022$5,284,000
+178.0%
223,460
+107.9%
0.00%
Q4 2021$1,901,000
-88.7%
107,467
-82.0%
0.00%
-100.0%
Q3 2021$16,815,000596,0570.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$7,732,4086.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$18,872,3071.01%
COWEN AND COMPANY, LLC 3,116,996$10,286,0860.85%
RA Capital Management 11,609,704$38,312,0230.72%
RTW INVESTMENTS, LP 6,064,123$20,011,6060.38%
Simplify Asset Management Inc. 696,296$2,297,7770.30%
Acuitas Investments, LLC 134,815$444,8900.26%
Vivo Capital, LLC 550,000$1,815,0000.12%
Opaleye Management Inc. 143,600$473,8800.11%
HARVARD MANAGEMENT CO INC 341,972$1,1290.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders